J&J Must Pay $72 Million Over Talc Tied to Woman’s Cancer
Johnson & Johnson must pay $72 million to the family of a woman who blamed her fatal ovarian cancer on the company’s talcum powder in the first state-court case over the claims to go to trial.
Jurors in St. Louis on Monday concluded J&J should pay $10 million in compensatory damages and $62 million in...
FDA Reclassifies Surgical Mesh for Pelvic Organ Prolapse as ‘High Risk’
Olympus played down early report of superbug infections linked to duodenoscope devices
Earlier this year, Olympus came under fire after its duodenoscope devices were implicated in superbug outbreaks at medical centers in the U.S. But the company's questionable practices regarding the products date further back, as Olympus played down an early report of a superbug outbreak linked to its device overseas.
Read...
Moulton, Tsongas among Congress members urging FDA to reconsider OxyContin use among children
F.D.A. Targets Inaccurate Medical Tests, Citing Dangers and Costs
WASHINGTON — Inaccurate and unreliable medical tests are prompting abortions, promoting unnecessary surgeries, putting tens of thousands of people on unneeded drugs and raising medical costs, the Food and Drug Administration has concluded.
Read more.
Risk of Off-Label Uses for Prescription Drugs
About 12% of drugs doctors prescribe are for uses other than those approved by regulators, a recent study found. So-called off-label prescribing significantly raises the rate of negative side effects, the research showed.
Read more.
Makers of Nutritional Supplements Charged in Federal Sweep
A yearlong federal investigation into the dietary supplement industry has resulted in a widespread crackdown on the sale of tainted or misleading products.
The Justice Department said on Tuesday that it filed criminal and civil enforcement actions against 117 companies and individuals.
Read More
AbbVie’s Hepatitis C Drugs Label Changed After Patient Deaths
Seven patients on AbbVie Inc.’s drugs for hepatitis C died after liver failure, prompting U.S. regulators to change their advice on how the medicine should be administered.
Doctors should monitor patients using Viekira Pak or Technivie for signs of worsening liver disease, the U.S. Food and Drug Administration said in a statement Thursday. The medication...
FDA staff reviewers question safety of AstraZeneca’s gout drug
(Reuters) - Staff reviewers of the U.S. Food and Drug Administration have raised questions about the safety of AstraZeneca Plc's gout treatment.
Reviewers pointed to higher death rates, cardiovascular issues and kidney-related side effects in patients who took the drug, lesinurad, a preliminary review published on Wednesday showed.
Read More
Lawmakers push ban on herbal Viagra after Odom’s overdose
ALBANY — Lamar Odom’s near-deadly binge on drugs, hookers and herbal sex supplements has moved two state lawmakers to take a hard look at stopping so-called herbal Viagra.
“This incident raises serious concerns about FDA enforcement of prescription drugs,” said state Sen. Jeff Klein (D-Bronx).
Read More
